Population Pharmacokinetics of Cabotegravir Following Oral Administration and Long‐Acting Intramuscular Injection in Real‐World People with HIV

Documenti analoghi

• Population pharmacokinetic analysis of doravirine in real‐world people with HIV
  di: Paul Thoueille, et al.
  Pubblicazione: (2024)
• Frequent hepatitis B surface antigen ( HBsAg) clearance during tenofovir therapy in persons with HIV /hepatitis B virus coinfection
  di: Charles Béguelin, et al.
  Pubblicazione: (2025)
• Do people with HIV really have the choice between oral and injectable ART ? Evidence from a multicentric survey in the Swiss HIV cohort study
  di: Yonas Martin, et al.
  Pubblicazione: (2026)
• Strategies to Manage Dosing Deviations and Interruptions of Cabotegravir Long‐Acting Intramuscular Injections
  di: Kelong Han, et al.
  Pubblicazione: (2025)
• The dimensional model of language universals / Hansjakob Seiler
  di: Seiler, Hansjakob
  Pubblicazione: (1986)